This consultation closed on Tuesday, 30 March 2021.
The Therapeutic Goods Administration (TGA) sought to understand potential obstacles and incentives to repurposing of prescription medicines that may influence a sponsor's decision to extend an indication for an existing medicine. To assist in identifying potential regulatory and reimbursement policy options and further consultation may occur.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.